Remibrutinib (Rhapsido)
Rhapsido is indicated for the treatment of chronic spontaneous urticaria (CSU) in adult patients with inadequate response to H1 antihistamine treatment.
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Rhapsido is indicated for the treatment of chronic spontaneous urticaria (CSU) in adult patients with inadequate response to H1 antihistamine treatment.
To treat chronic spontaneous urticaria in adults who remain symptomatic despite H1 antihistamine treatment